Itexsepicim Capsule

Adult dose

(Capsules) Adults: Administer 50～100mg (potency) of cefixime orally twice daily. For severe cases or when the effect is insufficient, administer 200mg (potency) twice daily. Adjust the dose as appropriate according to age and symptoms.

Child dose

(Capsules) Children weighing 30 Kg or more: Administer 50～100mg (potency) of cefixime orally twice daily. For severe cases or when the effect is insufficient, administer 200mg (potency) twice daily. (Powder) Children: Administer 1.5～3mg (potency) of cefixime per Kg of body weight orally twice daily. For severe cases or when the effect is insufficient, administer 6mg (potency) per Kg of body weight twice daily. Adjust the dose as appropriate according to age and symptoms.

This medication should not be administered to certain patients. In particular, patients who have previously experienced a severe allergic reaction or shock due to this medication, those with hypersensitivity to cephalosporin antibiotics, and patients with lactose intolerance or specific genetic metabolic disorders should not use it. Additionally, caution is required for patients with a history of hypersensitivity, severely impaired renal function, allergic constitution, elderly patients, and those who have difficulty taking medications orally, and dosage and administration intervals may need adjustment. This medication can rarely cause severe side effects, so if symptoms such as discomfort, respiratory distress, rash, severe diarrhea, skin rashes, liver dysfunction, or decreased kidney function appear during use, it is important to stop taking the medication immediately and consult healthcare professionals. Furthermore, this medication may affect the production of vitamin K, which can impact blood coagulation; hence, caution is necessary when used with anticoagulants such as warfarin. Pregnant or breastfeeding women should use this medication only if necessary, as its safety has not been established, and it is advisable to avoid breastfeeding during the treatment period. Safety has also not been established for neonates and infants under 6 months, so its use should be avoided. Regular monitoring of liver and kidney function through periodic tests should be conducted during the use of this medication, and any unusual symptoms should be reported to healthcare professionals immediately. Lastly, this drug contains specific dye components, so caution is also warranted for patients allergic to these components.

• Shock
• discomfort
• oral dysesthesia
• wheezing
• dizziness
• bowel movements
• tinnitus
• sweating
• anaphylactic symptoms
• shortness of breath

Store this medication in a tightly sealed container to prevent air and moisture from entering. It is also recommended to keep the medication at room temperature, avoiding extremes of heat or cold, ideally between 1 to 30 degrees Celsius.

Appearance

A hard capsule with a light orange upper and lower part filled with a white to light yellow crystalline powder.

Package unit

30 capsules, 60 capsules